Amlenetug (Lu AF82422)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Amlenetug (Lu AF82422), covering 2026-06-04 to 2026-06-04. Get the full timeline:
Most recent: Clinical Trial Update: A Trial of Amlenetug (Lu AF82422) in Participants With Multiple System Atrophy (MSA) [Phase 3]